South and Central America Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

Publisher Name :
Date: 31-Jan-2013
No. of pages: 91

South and Central America Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

Summary

GlobalData’s new report, “South and Central America Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others” provides key market data on the South and Central America Drug Delivery Devices market – Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Countries covered include Argentina, Brazil and Mexico.
- Market size and company share data for Drug Delivery Devices market categories – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the South and Central America Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Cipla Medpro (Pty) Ltd., Hospira, Inc. and Baxter International Inc.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South and Central America Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

South and Central America Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Drug Delivery Devices in South and Central America 10
3.1 Drug Delivery Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10
3.2 Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 11
3.3 Drug Delivery Devices, South and Central America, Company share (2010-2011) 18
4 Drug Delivery Devices In Argentina 20
4.1 Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 20
4.2 Drug Delivery Devices, Argentina, Distribution Share (2010-2011) 26
4.2.1 Central Venous Catheters, Argentina, Distribution Share (2010-2011) 26
4.2.2 Infusion Systems, Argentina, Distribution Share (2010-2011) 26
4.2.3 Metered Dose Inhaler Devices, Argentina, Distribution Share (2010-2011) 27
4.2.4 Needle Free Injections, Argentina, Distribution Share (2010-2011) 27
4.3 Drug Delivery Devices, Argentina, Company Share (2010-2011) 28
4.3.1 Drug Delivery Devices, Argentina, Company Share (2010-2011) 28
4.3.2 Central Venous Catheters, Argentina, Company Share (2010-2011) 30
4.3.3 Infusion Systems, Argentina, Company Share (2010-2011) 32
4.3.4 Metered Dose Inhaler Devices, Argentina, Company Share (2010-2011) 34
4.3.5 Needle Free Injections, Argentina, Company Share (2010-2011) 35
5 Drug Delivery Devices In Brazil 36
5.1 Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 36
5.2 Drug Delivery Devices, Brazil, Distribution Share (2010-2011) 42
5.2.1 Central Venous Catheters, Brazil, Distribution Share (2010-2011) 42
5.2.2 Infusion Systems, Brazil, Distribution Share (2010-2011) 42
5.2.3 Metered Dose Inhaler Devices, Brazil, Distribution Share (2010-2011) 43
5.2.4 Needle Free Injections, Brazil, Distribution Share (2010-2011) 43
5.3 Drug Delivery Devices, Brazil, Company Share (2010-2011) 44
5.3.1 Drug Delivery Devices, Brazil, Company Share (2010-2011) 44
5.3.2 Central Venous Catheters, Brazil, Company Share (2010-2011) 46
5.3.3 Infusion Systems, Brazil, Company Share (2010-2011) 48
5.3.4 Metered Dose Inhaler Devices, Brazil, Company Share (2010-2011) 50
5.3.5 Needle Free Injections, Brazil, Company Share (2010-2011) 51
6 Drug Delivery Devices in Mexico 52
6.1 Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 52
6.2 Drug Delivery Devices, Mexico, Distribution Share (2010-2011) 58
6.2.1 Central Venous Catheters, Mexico, Distribution Share (2010-2011) 58
6.2.2 Infusion Systems, Mexico, Distribution Share (2010-2011) 58
6.2.3 Metered Dose Inhaler Devices, Mexico, Distribution Share (2010-2011) 59
6.2.4 Needle Free Injections, Mexico, Distribution Share (2010-2011) 59
6.3 Drug Delivery Devices, Mexico, Company Share (2010-2011) 60
6.3.1 Drug Delivery Devices, Mexico, Company Share (2010-2011) 60
6.3.2 Central Venous Catheters, Mexico, Company Share (2010-2011) 62
6.3.3 Infusion Systems, Mexico, Company Share (2010-2011) 64
6.3.4 Metered Dose Inhaler Devices, Mexico, Company Share (2010-2011) 66
6.3.5 Needle Free Injections, Mexico, Company Share (2010-2011) 67
7 Overview of Key Companies in South and Central America Drug Delivery Devices Market 68
7.1 GlaxoSmithKline plc 68
7.1.1 Company Overview 68
7.1.2 Share in the South and Central America Drug Delivery Devices Market 68
7.2 Boehringer Ingelheim GmbH 69
7.2.1 Company Overview 69
7.2.2 Share in the South and Central America Drug Delivery Devices Market 69
7.3 AstraZeneca PLC 70
7.3.1 Company Overview 70
7.3.2 Share in the South and Central America Drug Delivery Devices Market 70
7.4 Baxter International Inc. 71
7.4.1 Company Overview 71
7.4.2 Share in the South and Central America Drug Delivery Devices Market 71
7.5 Hospira, Inc. 72
7.5.1 Company Overview 72
7.5.2 Share in the South and Central America Drug Delivery Devices Market 72
7.6 B. Braun Melsungen AG 73
7.6.1 Company Overview 73
7.6.2 Share in the South and Central America Drug Delivery Devices Market 73
7.7 Fresenius Kabi AG 74
7.7.1 Company Overview 74
7.8 Teleflex Incorporated 74
7.8.1 Company Overview 74
7.9 Terumo Corporation 74
7.9.1 Company Overview 74
7.10 Medtronic, Inc. 75
7.10.1 Company Overview 75
7.11 Smiths Medical 75
7.11.1 Company Overview 75
7.12 CareFusion Corporation 75
7.12.1 Company Overview 75
7.13 3M Health Care Ltd. 76
7.13.1 Company Overview 76
7.14 C. R. Bard, Inc. 76
7.14.1 Company Overview 76
7.15 Edwards Lifesciences Corporation 76
7.15.1 Company Overview 76
7.16 Consort Medical plc 77
7.16.1 Company Overview 77
7.17 Arcomed AG 77
7.17.1 Company Overview 77
7.18 Nipro Corporation 77
7.18.1 Company Overview 77
7.19 Universal Medical Technologies Inc. 78
7.19.1 Company Overview 78
7.20 Becton, Dickinson and Company 78
7.20.1 Company Overview 78
7.21 Cook Medical Incorporated 78
7.21.1 Company Overview 78
7.22 INJEX - Equidyne Systems 79
7.22.1 Company Overview 79
7.23 Samtronic 79
7.23.1 Company Overview 79
7.24 Lifemed Ind. de Equipamentos e Art. Medicos Hospitalares S.A 79
7.24.1 Company Overview 79
7.25 PharmaJet, Inc. 79
7.25.1 Company Overview 79
8 Drug Delivery Devices Market Pipeline Products 80
9 Financial Deals Landscape 85
9.1 Partnerships 85
9.1.1 Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 85
9.1.2 Echo Therapeutics Expands Licensing Agreement With Ferndale Pharma 86
10 Appendix 87
10.1 Definitions of Markets Covered in the Report 88
10.1.1 Drug Delivery Devices 88
10.2 Research Methodology 89
10.3 Secondary Research 89
10.4 Primary Research 89
10.5 Models 90
10.6 Forecasts 90
10.7 Expert Panels 90
10.8 GlobalData Consulting 91
10.9 Currency Conversion 91
10.10 Contact Us 91
10.11 Disclaimer 91

1.1 List of Tables
Table 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 10
Table 2: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 12
Table 3: Drug Delivery Devices, South and Central America, Cross-Category Analysis, 2004-2018 13
Table 4: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 15
Table 5: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 17
Table 6: Drug Delivery Devices, South and Central America, Company share by Revenue ($m), USD Constant, 2010-2011 19
Table 7: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 21
Table 8: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-2011 23
Table 9: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 25
Table 10: Central Venous Catheters, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 26
Table 11: Infusion Systems, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 26
Table 12: Metered Dose Inhaler Devices, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 27
Table 13: Needle Free Injections, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011 27
Table 14: Drug Delivery Devices, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 29
Table 15: Central Venous Catheters, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 31
Table 16: Infusion Systems, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 33
Table 17: Metered Dose Inhaler Devices, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 34
Table 18: Needle Free Injections, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011 35
Table 19: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 37
Table 20: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 39
Table 21: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 41
Table 22: Central Venous Catheters, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 42
Table 23: Infusion Systems, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 42
Table 24: Metered Dose Inhaler Devices, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 43
Table 25: Needle Free Injections, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 43
Table 26: Drug Delivery Devices, Brazil, Company Share, USD Constant, (2010-2011) 45
Table 27: Central Venous Catheters, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 47
Table 28: Infusion Systems, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 49
Table 29: Metered Dose Inhaler Devices, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 50
Table 30: Needle Free Injections, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 51
Table 31: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 53
Table 32: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Historic, 2004-2011 55
Table 33: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 57
Table 34: Central Venous Catheters, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 58
Table 35: Infusion Systems, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 58
Table 36: Metered Dose Inhaler Devices, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59
Table 37: Needle Free Injections, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59
Table 38: Drug Delivery Devices, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 61
Table 39: Central Venous Catheters, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 63
Table 40: Infusion Systems, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 65
Table 41: Metered Dose Inhaler Devices, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 66
Table 42: Needle Free Injections, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011 67
Table 43: Drug Delivery DevicesMarket Pipeline Products 80
Table 44: Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 85
Table 45: Echo Therapeutics Expands Licensing Agreement With Ferndale Pharma 86

1.2 List of Figures
Figure 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10
Figure 2: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018 11
Figure 3: Drug Delivery Devices, South and Central America, Cross-Category Analysis, by Revenue ($m), USD Constant, 2004-2018 13
Figure 4: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Historic, 2004-2011 14
Figure 5: Drug Delivery Devices, South and Central America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 16
Figure 6: Drug Delivery Devices, South and Central America, Company share (%), 2011 18
Figure 7: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, 2004-2018 20
Figure 8: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-2011 22
Figure 9: Drug Delivery Devices, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 24
Figure 10: Drug Delivery Devices, Argentina, Company Share (%), 2011 28
Figure 11: Central Venous Catheters, Argentina, Company Share (%), 2011 30
Figure 12: Infusion Systems, Argentina, Company Share (%), 2011 32
Figure 13: Metered Dose Inhaler Devices, Argentina, Company Share (%), 2011 34
Figure 14: Needle Free Injections, Argentina, Company Share (%), 2011 35
Figure 15: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 36
Figure 16: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 38
Figure 17: Drug Delivery Devices, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 40
Figure 18: Drug Delivery Devices, Brazil, Company Share (%), 2011 44
Figure 19: Central Venous Catheters, Brazil, Company Share (%), 2011 46
Figure 20: Infusion Systems, Brazil, Company Share (%), 2011 48
Figure 21: Metered Dose Inhaler Devices, Brazil, Company Share (%), 2011 50
Figure 22: Needle Free Injections, Brazil, Company Share (%), 2011 51
Figure 23: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, 2004-2018 52
Figure 24: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Historic, 2004-2011 54
Figure 25: Drug Delivery Devices, Mexico, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 56
Figure 26: Drug Delivery Devices, Mexico, Company Share (%), 2011 60
Figure 27: Central Venous Catheters, Mexico, Company Share (%), 2011 62
Figure 28: Infusion Systems, Mexico, Company Share (%), 2011 64
Figure 29: Metered Dose Inhaler Devices, Mexico, Company Share (%), 2011 66
Figure 30: Needle Free Injections, Mexico, Company Share (%), 2011 67
Figure 31: GlaxoSmithKline plc, Company Share (%), South and Central America Drug Delivery Devices Market, 2011 68
Figure 32: Boehringer Ingelheim GmbH, Company Share (%), South and Central America Drug Delivery Devices Market, 2011 69
Figure 33: AstraZeneca PLC, Company Share (%), South and Central America Drug Delivery Devices Market, 2011 70
Figure 34: Baxter International Inc., Company Share (%), South and Central America Drug Delivery Devices Market, 2011 71
Figure 35: Hospira, Inc., Company Share (%), South and Central America Drug Delivery Devices Market, 2011 72
Figure 36: B. Braun Melsungen AG, Company Share (%), South and Central America Drug Delivery Devices Market, 2011 73
  • Most Effective Treatments For Diabetes
    Diabetes is a chronic metabolic disease leading to high blood sugar because or troubled insulin secretion. There are two types of diabetes – type 1 and type 2. Type 1 or juvenile diabetes causes when the body fails to produce enough insulin. Type 2 on the other hand causes when the body cells have lower [...]
  • Importance of Educational Books Publishing
    Education plays a crucial role in overall development of a person and the entire society. Students across the globe and various educational levels depend on study material. Whether they are textbooks, reference books or workbooks, they are in a constant need for systematic educational books. Educational book publishing is a versatile crucial branch of book [...]
  • How to Treat Arthritis Effectively ?
    The word arthritis stands for inflammation of joints. It is an umbrella term for over 100 diseases that cause pain, discomfort, disability and several other symptoms amongst individuals. Osteoarthritis is one of the most common types of arthritis, which affects elderly. Several other forms of this disease may affect individuals at a very young age [...]
  • Benefits of Set top Boxes Amidst the Wave of Digitization
    A set top unit or box is a useful device that provides content through television sets. Set top box is a term that refers to a device, which is used for broadcasting the content. It is different from the devices that help simple recording of media, such as DVDs. Cable operators and satellite companies provide [...]
  • What are the Treatments for Alzheimer’s Disease ?
    Alzheimer’s disease is one of the most common types of dementia. Dementia is the condition defined by significant loss of global cognitive ability in a healthy person. This loss is beyond the normal aging process and it only worsens with the age. Alzheimer’s disease is a serious mental health condition and a progressive brain disease [...]
  • Foresight 2020: Network Development in a Multi-Channel World
  • London, May 24th, 2013 – As the costs of branch banking increased in the 80s and 90s, banks attempted to reduce costs by reliance on centers, mobile and online channels to lower costs and improve service. The digitization of banks …

  • Italy Healthcare Industry Regulatory and Reimbursement Landscape
  • The Italian Pharmaceutical Market has Declined in Value Terms Due to the Introduction of Price Cuts and Increasing Focus on the Usage of Generic Drugs in Order to Rein in Ballooning Healthcare Expenditure   The pharmaceutical market (at the consumer …

  • Men’s Health & Midlife Women Consumer Market Research Reports
  • RnRMarketResearch.com offers new market research reports on masculinity Vs health and midlife women embracing power and avoiding invisibility in global consumer markets.   “Masculinity Vs Health: Challenges and Opportunities” and “Midlife Women: Embracing Power and Avoiding Invisibility in Global Consumer …

  • France Healthcare Market Regulatory and Reimbursement Landscape
  • France has a Mature Healthcare Market as it Offers Universal Public Access to Healthcare Facilities and Insurance. The Increasing Disease Burden and the Launch of New Products will Drive the Growth of the Pharmaceutical Market; however, Increasing Focus on Generics …

  • Lebanon Cards and Payments Industry Worth 2.4 Million Cards By 2017
  • Between 2008 and 2012, Lebanon’s cards industry recorded a CAGR of 4.89% in terms of volume and the total number of cards increased from 1.6 million to 2.0 million. The industry has been forecasted to grow at a CAGR of …

  • Nanotechnology Drug Delivery Market in the US 2012-2016
    "...... the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the growth of this market. TechNavio''s report, the Nanotechnology Drug Delivery Market in the US 2012-2016, has been prepared bas......"
  • North America Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
    "......l Venous Catheters and Others" provides key market data on the North America Drug Delivery Devices market - United States and Canada. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion ......"
  • Europe Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
    "......ters and Others" provides key market data on the Europe Drug Delivery Devices market - United Kingdom, Germany, France, Italy and Spain. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusi......"
  • Asia-Pacific Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
    "......Venous Catheters and Others" provides key market data on the Asia Pacific Drug Delivery Devices market - Japan, China, India, and Australia. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, In......"
  • Middle East and Africa Drug Delivery Devices Market Outlook to 2018 – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
    "......on Systems, Central Venous Catheters and Others" provides key market data on the Middle East and Africa Drug Delivery Devices market - South Africa, Saudi Arabia and Israel.. The report provides value (USD million) data for all the market categories ......"